Cullinan Therapeutics senior leaders use personal experience to inspire clinical development

Cullinan Therapeutics senior leaders use personal experience to inspire clinical development
Cullinan Therapeutics leaders inspired by experience

Jerry Walis, Senior Director of GxP Quality Systems at Cullinan Therapeutics, shares how living with multiple autoimmune diseases motivates him to make a difference for others. He joined Antoine Sreih, Vice President and Medical Director of Clinical Development, to discuss how personal experience informs their commitment to advancing therapies.

The initiative reflects the company's emphasis on empathy-driven innovation within its clinical development teams. Cullinan Therapeutics continues to highlight the value of lived experience in shaping its approach to patient-focused drug development.

Earlier this year, Cullinan Therapeutics outlined a novel biomarker approach to address immune reset in autoimmune diseases. The company has also pursued T cell engager therapies targeting B cells to tackle root causes of these conditions. These efforts come as Cullinan emphasizes patient experience within its development strategies.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.